staurosporine has been researched along with Sarcoma, Ewing in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, KL; Brunak, S; Emdal, KB; Huber, KV; Kovar, H; Mutz, C; Olsen, JV; Papamarkou, T; Radic-Sarikas, B; Superti-Furga, G; Toretsky, JA; Tsafou, KP | 1 |
| Boro, A; Niggli, FK; Oesch, S; Prêtre, K; Rechfeld, F; Schäfer, BW; Thalhammer, V; Wachtel, M | 1 |
2 other study(ies) available for staurosporine and Sarcoma, Ewing
| Article | Year |
|---|---|
Combinatorial Drug Screening Identifies Ewing Sarcoma-specific Sensitivities.
Topics: Animals; Antigens, CD; Antineoplastic Agents; Cell Line, Tumor; Computational Biology; Disease Models, Animal; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Drug Screening Assays, Antitumor; Humans; Molecular Targeted Therapy; Oncogene Proteins, Fusion; Phosphorylation; Protein Kinase Inhibitors; Proteomics; Proto-Oncogene Protein c-fli-1; Receptor, IGF Type 1; Receptor, Insulin; Receptors, Somatomedin; RNA-Binding Protein EWS; Sarcoma, Ewing; Signal Transduction; Staurosporine; Xenograft Model Antitumor Assays | 2017 |
Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caveolin 1; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Homeobox Protein Nkx-2.2; Homeodomain Proteins; Humans; Mice; Mice, Inbred NOD; Nuclear Proteins; Oncogene Proteins, Fusion; Proto-Oncogene Protein c-fli-1; Random Allocation; RNA Interference; RNA-Binding Protein EWS; RNA, Small Interfering; Sarcoma, Ewing; Small Molecule Libraries; Staurosporine; Transcription Factors; Xenograft Model Antitumor Assays; Zebrafish Proteins | 2012 |